- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8543
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,543 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 206.60 | 0.1% | 99.0% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
AOT | CA$0.16 | -8.6% | -61.0% | CA$113.0m | n/a | PS46.7x | E46.9% | n/a | Materials | ||
CADLR | NOK 70.80 | 1.9% | 92.2% | NOK 24.8b | NOK 81.94 | PS17.3x | E67.8% | n/a | Capital Goods | ||
GAU | CA$1.96 | -2.0% | 117.8% | CA$501.0m | CA$3.30 | PE38.4x | E31.2% | n/a | Materials | ||
ZVRA | US$7.58 | -2.6% | 58.2% | US$424.1m | US$18.80 | PS16.8x | E69.4% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.15 | 9.3% | 75.2% | €123.8m | €12.75 | PE25.2x | E22.8% | n/a | Capital Goods | ||
SCOL | SEK 0.14 | 10.0% | -90.4% | SEK 33.2m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$91.56 | -0.9% | 29.5% | US$4.6b | US$125.24 | PS15.1x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$14.51 | 1.7% | 80.2% | US$1.2b | US$17.60 | PS6.2x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
EH | US$11.77 | -0.9% | -30.3% | US$753.7m | US$24.76 | PS21.1x | E81.5% | n/a | Capital Goods | ||
AESI | US$23.23 | 8.7% | -2.2% | US$2.5b | US$26.00 | PE17.5x | E42.1% | 4.0% | Energy | ||
SRPT | US$124.79 | 0.4% | 8.8% | US$12.1b | US$194.36 | PE251.6x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$29.79 | 7.3% | 100.2% | US$4.8b | US$35.33 | PS22.7x | E95.0% | n/a | Semiconductors | ||
KEBNI B | SEK 1.12 | -6.0% | -7.4% | SEK 303.7m | SEK 2.20 | PS2.6x | E86.1% | n/a | Tech | ||
ARES | US$156.25 | 4.6% | 47.8% | US$49.0b | US$150.23 | PE82.5x | E32.9% | 2.4% | Diversified Financials | ||
NVDA | US$116.26 | -0.4% | 175.4% | US$2.8t | US$148.83 | PE53.8x | E22.3% | 0.03% | Semiconductors | ||
TGTX | US$23.25 | -6.6% | 158.9% | US$3.5b | US$33.75 | PE34.9x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.18 | 0% | -17.6% | SEK 77.1m | SEK 8.00 | PS4.2x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
GGP | UK£0.064 | 1.4% | -0.2% | UK£325.3m | n/a | PB6.5x | E48.8% | n/a | Materials | ||
A253590 | ₩8,430.00 | -4.2% | 123.0% | ₩357.9b | n/a | PE64.3x | E71.3% | 0.4% | Semiconductors | ||
A178320 | ₩27,200.00 | 6.3% | 78.5% | ₩1.5t | ₩39,333.33 | PE29.5x | E52.1% | 0% | Tech | ||
4480 | JP¥3,420.00 | 3.5% | -30.8% | JP¥111.9b | JP¥5,400.00 | PE41.3x | E30.4% | n/a | Healthcare | ||
AV1 | AU$0.076 | 24.6% | 68.9% | AU$57.6m | n/a | PS14.4x | E144.2% | n/a | Software | ||
CUV | AU$14.36 | -5.3% | -3.6% | AU$718.5m | AU$29.17 | PE20.2x | E27.4% | 0.3% | Pharmaceuticals & Biotech |